Earnings season is winding down, with most companies already having reported their quarterly results. But there are still some companies left to report, and Antares Pharma Inc (NASDAQ:ATRS) is about to release its quarterly earnings. The key to making smart investment decisions with stocks releasing their quarterly reports is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you’ll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.
Antares has the word “pharma” in its name, but the company stands out as much for how it’s trying to change the way patients take drugs as for the effectiveness of the drugs themselves. Let’s take an early look at what’s been happening with Antares Pharma over the past quarter and what we’re likely to see in its quarterly report on Wednesday.
Stats on Antares Pharma Inc (NASDAQ:ATRS)
|Analyst EPS Estimate||($0.03)|
|Revenue Estimate||$5.36 million|
|Change From Year-Ago Revenue||(1.2%)|
|Earnings Beats in Past 4 Quarters||1|